The Supreme Court heard oral arguments on Tuesday about who is liable for a faulty generic drug.
A woman who took a pain killer ended up losing much of her skin, had to be put in a drug-induced coma and is now blind. The manufacturer says they are not liable because they make the drug exactly as the brand manufacturer did and the FDA approved it.
Host Carmen Russell-Sluchansky spoke with Andre M. Mura, litigation counsel for the Center for Constitutional Litigation, to discuss the case.
Podcast: Play in new window | Download
